Volume 64 Received 24 May 2008 | ||||||||||
| ||||||||||
N1)dichloridocopper(II) monohydrateaX-ray Crystallography Unit, School of Physics, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia,bDepartment of Electronics, St Joseph's College, Tiruchirappalli 620 001, India, and cDepartment of Physics, Karunya University, Karunya Nagar, Coimbatore 641 114, India
Correspondence e-mail: hkfun@usm.my
The asymmetric unit of the title compound, [CuCl2(C5H6N2)4]·H2O, contains two crystallographically independent complex molecules and two water molecules. The CuII ion in each molecule is six-coordinated in an elongated octahedral geometry, with the equatorial plane defined by four pyridine N atoms of four aminopyridine ligands and the axial positions occupied by two Cl atoms. In the crystal structure, molecules are linked into a three-dimensional framework by C-H
Cl, O-H
Cl, N-H
O, N-H
Cl and N-H
N hydrogen bonds and C/N-H
interactions involving the pyridine rings.
For related literature on 4-aminopyridine, see: Judge & Bever (2006
); Schwid et al. (1997
); Strupp et al. (2004
). For bond lengths, see: Moncol et al. (2004
); Zaleski et al. (2005
); Anderson et al. (2005
).
|
|
|
Data collection: APEX2 (Bruker, 2005
); cell refinement: APEX2; data reduction: SAINT (Bruker, 2005
); program(s) used to solve structure: SHELXTL (Sheldrick, 2008
); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2003
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: CI2603 ).
HKF and SRJ thank the Malaysian Government and Universiti Sains Malaysia for Science Fund Grant No. 305/PFIZIK/613312. SRJ thanks the Universiti Sains Malaysia for a post-doctoral research fellowship.
Anderson, F. P., Gallagher, J. F., Kenny, P. T. M. & Lough, A. J. (2005). Acta Cryst. E61, o1350-o1353.
![[details]](../../../../../../e/graphics/details.gif)
Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Judge, S. & Bever, C. (2006). Pharmacol. Ther. 111, 224-259.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Moncol, J., Mudra, M., Lonnecke, P., Koman, M. & Melink, M. (2004). J. Chem. Crystallogr. 34, 423-431.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Schwid, S. B., Petrie, M. D., McDermott, M. P., Tierney, D. S., Mason, D. H. & Goodman, A. D. (1997). Neurology, 48, 817-821.
![[ISI]](../../../../../../logos/isiborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.
![[details]](../../../../../../j/graphics/details.gif)
Strupp, M., Kalla, R., Dichgans, M., Fraitinger, T., Glasauer, S. & Brandt, T. (2004). Neurology, 62, 1623-1625.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Zaleski, J., Gabryszewski, M. & Zarychta, B. (2005). Acta Cryst. C61, m151-m154.
![[details]](../../../../../../c/graphics/details.gif)